nigericin has been researched along with Staphylococcal Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Deng, X; He, G; Hong, A; Hu, Z; Huang, D; Li, L; Luo, H; Sun, X; Wang, W; Wu, X; Wu, Z; Xu, Q; Zhao, X; Zhu, X | 1 |
Brunner, C; Daiber, E; Dang, TM; Delmiro Garcia, M; Dickhöfer, S; Dillen, C; Franz-Wachtel, M; Grimbacher, B; Hartl, D; Kraus, H; Kümmerle-Deschner, J; Latz, E; Liu, X; Macek, B; Miller, L; Münzenmayer, L; Pichulik, T; Radsak, M; Rieber, N; Schulte, B; Stilgenbauer, S; Stutz, A; Vogel, S; Wahl, S; Walz, JS; Weber, ANR; Wolz, C; Wolz, OO; Yazdi, A | 1 |
2 other study(ies) available for nigericin and Staphylococcal Infections
Article | Year |
---|---|
Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nigericin; Staphylococcal Infections | 2022 |
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Topics: Adaptive Immunity; Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Animals; Apoptosis Regulatory Proteins; Bacterial Proteins; Cells, Cultured; Cryopyrin-Associated Periodic Syndromes; Genetic Diseases, X-Linked; Humans; Immunity, Innate; Inflammasomes; Lamin B Receptor; Leukocidins; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Protein-Tyrosine Kinases; Proteomics; Pyrin Domain; Receptors, Cytoplasmic and Nuclear; Staphylococcal Infections; Staphylococcus aureus | 2017 |